Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Katz

Showing results (641-650 of 749) with videos related to

Pageof 75
Sort By:
Cancers|October 16, 2024
The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyMehran Taherian, Matthew H G Katz, Laura R Prakash, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Cancers|May 13, 2023
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and PancreatectomyYi Tat Tong, Zongshan Lai, Matthew H G Katz, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 7, 2023
Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal CriteriaArtem Boyev, Ahad Azimuddin, Timothy E Newhook, et al.
Annals of Surgical Oncology|September 11, 2025
Association Between Intraoperative Hypothermia and Postoperative Pancreatic FistulaMaho Takayama, Rebecca A Snyder, Heather G Lyu, et al.
American Journal of Surgery|December 18, 2019
Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resectionEmily Z Keung, Elliot A Asare, Yi-Ju Chiang, et al.
Annals of Surgery|October 4, 2023
Classification of Post-pancreatectomy Readmissions and Opportunities for Targeted Mitigation StrategiesArtem Boyev, Ahad Azimuddin, Laura R Prakash, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 31, 2012
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resectionRyan M Thomas, Mark J Truty, Graciela M Nogueras-Gonzalez, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine TumorsChirayu Mohindroo, Seyda Baydogan, Parul Agarwal, et al.
Journal of the American College of Surgeons|February 14, 2023
Differential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreaticoduodenectomy with Successive Refinements of Risk-Stratified Care PathwaysReed I Ayabe, Laura R Prakash, Morgan L Bruno, et al.
Pageof 75

Showing results (641-650 of 749) with videos related to

Sort By:
Pageof 75
Cancers|October 16, 2024
The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyMehran Taherian, Matthew H G Katz, Laura R Prakash, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 3, 2013
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancerChing-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, et al.
Cancers|May 13, 2023
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and PancreatectomyYi Tat Tong, Zongshan Lai, Matthew H G Katz, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 7, 2023
Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal CriteriaArtem Boyev, Ahad Azimuddin, Timothy E Newhook, et al.
Annals of Surgical Oncology|September 11, 2025
Association Between Intraoperative Hypothermia and Postoperative Pancreatic FistulaMaho Takayama, Rebecca A Snyder, Heather G Lyu, et al.
American Journal of Surgery|December 18, 2019
Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resectionEmily Z Keung, Elliot A Asare, Yi-Ju Chiang, et al.
Annals of Surgery|October 4, 2023
Classification of Post-pancreatectomy Readmissions and Opportunities for Targeted Mitigation StrategiesArtem Boyev, Ahad Azimuddin, Laura R Prakash, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 31, 2012
Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resectionRyan M Thomas, Mark J Truty, Graciela M Nogueras-Gonzalez, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 25, 2024
Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine TumorsChirayu Mohindroo, Seyda Baydogan, Parul Agarwal, et al.
Journal of the American College of Surgeons|February 14, 2023
Differential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreaticoduodenectomy with Successive Refinements of Risk-Stratified Care PathwaysReed I Ayabe, Laura R Prakash, Morgan L Bruno, et al.
Pageof 75